The Lancet Psychiatry· Sem Cohen, Edoardo Ostinelli, Akihiro Takamiya, Bram Storosum, Alexander Verweij, Joost Daams, Taina Mattila, Anthonius de Boer, Daniel Geller, Stefan Leucht, Dan Stein, Jasper Zantvoord, Andrea Cipriani, Damiaan Denys·· 9 天前AI 评分45
克洛米普胺与SSRIs治疗各年龄段强迫症疗效与耐受性比较
[Articles] Comparative efficacy and tolerability of pharmacological interventions for the acute treatment of obsessive-compulsive disorder across the lifespan: a systematic review and network meta-analysis
AI 导读
系统综述显示,克洛米普胺在治疗强迫症方面效果最佳,但耐受性低于SSRIs。儿童和青少年中,克洛米普胺优于单一SSRIs的效果更为显著。研究建议在个体化决策框架中权衡疗效与耐受性。
来源:The Lancet Psychiatry · thelancet.com